Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
Biotech
Novartis signs $1.1B deal for muscular dystrophy biotech
Novartis had one eye on the struggles its peers have encountered in the muscular dystrophy space when bought Kate Therapeutics, the pharma’s CEO said.
James Waldron
Nov 21, 2024 8:19am
Halozyme offers $2B for Evotec to expand beyond tech used by J&J
Nov 15, 2024 6:01am
BioNTech pays $800M to take control of potential Keytruda killer
Nov 13, 2024 6:45am
Evotec attracts private equity buyout interest: report
Nov 11, 2024 9:17am
AlloVir finds new identity via eye disease biotech merger
Nov 8, 2024 9:05am
Boston Scientific bolsters pulsed field ablation with Cortex buy
Nov 4, 2024 11:00am
